About
Janine Sengstack, PhD, is a cell biologist and entrepreneur best known as co-founder and Chief Scientific Officer of Junevity, a longevity biotech developing siRNA-based Cell Reset therapeutics. She earned her PhD in cellular aging from UC San Francisco in 2023, where she developed the core technology behind Junevity’s RESET platform. Public profiles and event materials also describe her as a frequent speaker on longevity, transcription factors, and age-related disease therapeutics.
Areas of interest
longevitybiotechcellular agingsiRNA therapeuticstranscription factorsage-related diseasesmetabolismneurodegenerative diseasesbioinformaticsAI in drug discovery